Lv1
40 积分 2025-12-10 加入
Guarding the frontiers: the biology of type III interferons
1个月前
已完结
Bacterial immunotherapy leveraging IL-10R hysteresis for both phagocytosis evasion and tumor immunity revitalization
1个月前
已完结
Engineering bispecific exosome activators of T cells to target immune checkpoint inhibitor-resistant metastatic melanoma
3个月前
已完结
Engineering lactate-modulating nanomedicines for cancer therapy
5个月前
已完结
皖公网安备34019202002308
